PolyPeptide Group is estimated to be 28% overvalued based on current share price of CHF32.90 ...
Tis the season for skincare! Don't wait until the last minute to secure your holiday gifts. Get a head start on shopping with ...
Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...
Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually ...
An update from Codexis ( (CDXS) ) is now available. Codexis, Inc. has appointed Raymond De Vré as a new Class I director to its Board, ...
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...
For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 ...
First, a little history on Epidermal Growth Factor: in the 1950s, the scientists who discovered EGF, which is a polypeptide or protein that our bodies produce throughout our lives, were awarded the ...
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical ...
A new guideline released on World Diabetes Day will give GPs and other health professionals positive recommendations for optimal diabetes management ...
They also include a combination of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, or GLP-1/GIP. Many of these GLP-1 and GLP-1/GIP receptor agonists were initially ...